CoRPS - Center of Research on Psychological disorders and Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Acta Oncol. 2023 Jul;62(7):737-743. doi: 10.1080/0284186X.2023.2245131. Epub 2023 Aug 23.
The prevalence of comorbid cardiovascular disease (CVD) among patients with colorectal cancer (CRC) has increased in the last decades. Previous studies have focused on the impact of comorbid CVD on clinical outcomes in CRC, while its impact on patients' health-related quality of life (HRQoL) is understudied. This study, therefore, relates (new-onset) CVD to HRQoL (i.e., physical, role, cognitive, emotional, and social functioning, and two CVD-related symptom scales fatigue and dyspnea) in a two-year follow-up study among CRC patients.
Newly diagnosed CRC patients from four Dutch hospitals were eligible for participation. Patients ( = 327) completed questions on HRQoL (EORTC QLQ-C30) and the presence and timing of CVDs before initial treatment (baseline) and one and two years after diagnosis.
CRC patients with comorbid CVD at cancer diagnosis ( = 72, 22%) reported significantly worse physical functioning at 2-year follow-up compared with patients who never had comorbid CVD ( < .05). CRC patients with new-onset CVD ( = 36, 11%) reported worse global QoL, worse role functioning, and more fatigue at 1 and 2-year follow-up compared with patients who never had comorbid CVD. In addition, they reported more dyspnea at baseline and worse physical functioning at 2-year follow-up ( < .05). Finally, patients with new-onset CVD reported worse global quality of life at 1-year follow-up and worse role functioning and more fatigue at 2-year follow-up, compared with patients with comorbid CVD at cancer diagnosis ( < .05). All significant differences between the three groups were of clinical relevance.
CRC patients with CVD, specifically those with new-onset CVD, reported a significantly and clinically relevant worse HRQoL compared with those who never had comorbid CVD. These findings seem to indicate, although the number is small, that CRC patients might have cardiovascular needs that need to be addressed and that multidisciplinary care is recommended. Larger studies are needed to confirm this.
在过去几十年中,患有结直肠癌(CRC)的患者合并心血管疾病(CVD)的患病率有所增加。以前的研究侧重于合并 CVD 对 CRC 临床结局的影响,而对其对患者健康相关生活质量(HRQoL)的影响研究较少。因此,本研究在 CRC 患者的两年随访研究中,将(新发)CVD 与 HRQoL(即身体、角色、认知、情感和社会功能以及两个与 CVD 相关的症状量表疲劳和呼吸困难)联系起来。
来自四家荷兰医院的新诊断 CRC 患者符合参与条件。患者( = 327)在初始治疗(基线)前和诊断后 1 年和 2 年完成了 HRQoL(EORTC QLQ-C30)问题和 CVD 的存在和时间。
癌症诊断时患有合并 CVD 的 CRC 患者( = 72,22%)在 2 年随访时报告身体功能明显更差,与从未合并 CVD 的患者相比( < .05)。新发 CVD 的 CRC 患者( = 36,11%)在 1 年和 2 年随访时报告全球 QoL 更差、角色功能更差且疲劳感更严重,与从未合并 CVD 的患者相比( < .05)。此外,他们在基线时报告了更多的呼吸困难,在 2 年随访时报告了更差的身体功能( < .05)。最后,新发 CVD 的患者在 1 年随访时报告全球生活质量更差,在 2 年随访时报告角色功能更差且疲劳感更严重,与癌症诊断时患有合并 CVD 的患者相比( < .05)。三组之间的所有显著差异均具有临床意义。
患有 CVD 的 CRC 患者,特别是新发 CVD 的患者,与从未合并 CVD 的患者相比,报告的 HRQoL 明显更差且具有临床意义。尽管数量较小,但这些发现似乎表明 CRC 患者可能存在需要解决的心血管需求,建议进行多学科护理。需要更大的研究来证实这一点。